There have been numerous studies on the inactivation of viruses for potential vaccine use (2, 3, 6, 7, 8, 10, 11, 12) . The methods of inactivation include the use of chemicals (e.g., formaldehyde, o-propiolactone, and ethylene oxide), physical forces [e.g., ultraviolet light (UV)], and a combination of these.
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This study was designed to investigate how Formalin, Merthiolate, a mixture of Merthiolate and Formalin, UV, and ,-propiolactone (BPL) affect the infectivity, hemagglutination (HA), and antigenicity of representative A, A2, and B strains of influenza virus.
MATERIALS AND METHODS
Viruses. The following influenza strains used in this study were part of the reagent collection maintained in our laboratory: A/PR/8/34, A2/Japan/170/62, A2/Georgia/1/67, and B/Massachusetts/3/66.
Method of preparing virus concentrates. Ten-to 11-day-old chicken embryos were inoculated into the allantoic sac with 0.2 ml of an appropriate dilution of seed virus. After incubation at 36 C, infectious allantoic fluids were harvested 48 hr later for the A and A2 strains and at 64 hr for the B strain. The pooled fluids were first centrifuged at 1,000 X g at 4 C for 30 min to remove the heavier debris. The clarified fluids were then centrifuged in a model L-2 Spinco by using an SW25.2 rotor at 53,000 X g for 1.5 hr at 4 C. The virus pellet was resuspended in a quantity of 0.01 M phosphate-buffered saline (PBS), pH 7.2, equal to H4o the original volume of allantoic fluid. To resuspend as much of the pellet as possible, it was necessary to sonic treat the final virus concentrate in a Raytheon sonic oscillator at 10 kc for 30 sec.
Formalin treatment. A 1-ml amount of stock 2% Formalin in PBS was added to 100 ml of virus concentrate. Final Formalin concentration was 1:5,000. Samples of this formalinized concentrate were removed after 18, 48, and 72 hr of incubation at 34 C.
Merthiolate treatment. A 1-ml amount of stock 1% Merthiolate in PBS was added to 100 ml of virus concentrate making a 1:10,000 final concentration of Merthiolate. Samples of this merthiolated concentrate were removed after 18, 48, and 72 hr of incubation at 34 C.
Merthiolate and Formalin. To a 100-ml sample of concentrate was added 1 ml of a stock 2% Formalin-1% Merthiolate solution. After incubation at 34 C, samples were removed at 18, 48, and 72 hr.
Control fluids. A portion of each viral concentrate before treatment was the zero-hour control. A 1-ml amount of PBS was added per 100-ml portion of concentrate. This mixture was incubated at 34 C along with the treated concentrates, and samples were removed at 18, 48, and 72 hr. (14) . The control for this procedure was 0.85% saline-1.68% sodium bicarbonate-0.2% phenol red solution.
UV light treatment. The virus concentrate was placed in 60-mm petri dishes and positioned to ensure an energy of 4,000 ergs per cm2 per sec. The fluid which had a depth of 3 mm was exposed for 3 or 6 min. The control was an untreated sample.
Dialysis. The controls and treated samples of the Formalin, Merthiolate, and Merthiolate-Formalin groups were subjected to dialysis immediately after the conclusion of the treatment period. The dialysis was performed with PBS for 3 hr at 4 C.
Infectivity measurement. Ten-to 11-day-old chicken embryos were used to measure infectivity. HA tests were performed on the allantoic fluids after incubation at 36 C for 48 hr for A and A2 strains and for 64 hr for B strains. All infectivity end points were determined by the Karber method (5).
Chicken cell agglutination (CCA). The method followed was that of Miller and Stanley (9) .
HA and hemagglutination-inhibition (HI). The method of Clarke and Casals (1) was modified for use in microtiter equipment (13) .
Antigenicity. Guinea pigs (National Institutes of Health-Hartley strain) of both sexes weighing 400 to 500 g were used for immunizations. Two Effect of inactivation on antigenicity. The values in Table 2 reflect the differences in the HI titer between animals inoculated with treated and zerohour control samples. We realize that the immunization procedures for the live virus controls and the treated samples were different. However, no matter what procedure was used, the antigenicity of an inactivated virus preparation would probably be directly related to the antigen mass, and the antigenicity of a live virus would depend upon both the antigen mass and the ability of the virus to replicate in that animal host. These limitations must be considered when evaluating the results. The zero-hour control titers served as a reference point for the purposes of this comparison. Although many more tests would probably be required to determine whether titer differences were significant, certain trends were noticeable. Formalin, Merthiolate and Formalin, and UV treatment for 6 min appeared to reduce consistently the antigenicity of the A/PR/8/34 strain. Merthiolate, Merthiolate and Formalin, and BPL seemed to have a deleterious effect on the A2/Ga/1 /67 strain, and BPL destroyed completely the antigenicity of the B/Mass/3/66 strain. The significance of this has yet to be determined.
DISCUSSION
Previous studies with viruses other than influenza revealed that BPL treatment did not affect HA or antigenicity (10) . It and antigenic properties of influenza virus. In contrast, the other methods of inactivation (i.e., Formalin, Merthiolate, and UV light) resulted in an increase in HA and CCA activity and no apparent change in antigenicity. The more severe action of BPL was also reflected in its ability to reduce infectivity quickly and markedly.
In general, Merthiolate is used as a preservative in biological products. The fact that it can also inactivate viruses such as influenza has been noted previously (4) . Our results corroborate these earlier findings.
Although there did not appear to be any strict relationship between HA and CCA values, nor between CCA value and antigenicity, the lack of sufficient testing precludes such a conclusion.
Considering the fact that the untreated controls contained live virus, our results showed that these samples demonstrate no greater HA or CCA content and antigenicity than the Formalin, Merthiolate, and UV-inactivated samples. Apparently, a period of inactivation greater than 18 hr was sufficient to reduce infectivity considerably without disturbing the antigenicity of the preparations.
The results of our antigenicity studies in guinea pigs revealed that one virus strain may react differently from another to a particular inactivating procedure. This would suggest that care must be exercised in attempting to apply conclusions obtained from the study of one virus group to another without experimentation. Since the antigenicity of BPL-treated influenza virus appears to be considerably reduced or destroyed, this method of treatment does not appear promising for influenza vaccine manufacture.
Our experiments revealed that combined treatment with Merthiolate and Formalin did not result in any greater loss in infectivity, nor any greater antigenicity, than treatment with either substance alone. Moreover, this combination of treatments may have reduced the antigenicity of two influenza strains as measured by HI antibody production in immunized guinea pigs.
With the development of newer methods of inactivating viruses for vaccine production, it is important to reevaluate the older methods. In this way, the technology for preparing killed vaccines can be updated and vaccines so produced can be improved.
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